Increased efficacy of a dendritic cell–based therapeutic cancer vaccine with adenosine receptor antagonist and CD73 inhibitor
Dendritic cells are important in initiating immune responses; therefore, a range of dendritic cell–based approaches have been established to induce immune response against cancer cells. However, the presence of immunosuppressive mediators such as adenosine in the tumor microenvironment reduces the e...
Saved in:
| Main Authors: | Samaneh Arab, Nasim Kheshtchin, Maryam Ajami, Mahbubeh Ashurpoor, Aida Safvati, Afshin Namdar, Reza Mirzaei, Neda Mousavi Niri, Farhad Jadidi-Niaragh, Mohammad Hossein Ghahremani, Jamshid Hadjati |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2017-03-01
|
| Series: | Tumor Biology |
| Online Access: | https://doi.org/10.1177/1010428317695021 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Feed-Forward Inhibition of CD73 and Upregulation of Adenosine Deaminase Contribute to the Loss of Adenosine Neuromodulation in Postinflammatory Ileitis
by: Cátia Vieira, et al.
Published: (2014-01-01) -
The metabolic milieu in melanoma: Role of immune suppression by CD73/adenosine
by: Anna Passarelli, et al.
Published: (2019-04-01) -
Altered CD73-Adenosine Signaling Linked to Infection in Patients undergoing hemodialysis
by: Xiang F, et al.
Published: (2025-01-01) -
The CD39/CD73/Adenosine and NAD/CD38/CD203a/CD73 Axis in Cutaneous T-Cell Lymphomas
by: Liyun Lin, et al.
Published: (2025-02-01) -
Research progress of CD73-adenosine signaling regulating hepatocellular carcinoma through tumor microenvironment
by: Liang Shan, et al.
Published: (2025-05-01)